|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of sales and operating expenses (note 11) | |||||
| Depreciation and amortization (note 11) | |||||
| New Zealand gas sale net proceeds (note 25) | |||||
| Egypt insurance recovery (note 26) | |||||
| Asset impairment charge (note 5) | |||||
| Operating income | |||||
| Impact of profit (loss) of equity-accounted investees reported net of tax | |||||
| Finance costs (note 12) | |||||
| Finance income and other | |||||
| Income before income taxes | |||||
| Income tax (expense) recovery (note 16): | |||||
| Current | |||||
| Deferred | |||||
| Total income tax expense | |||||
| Net income | |||||
| Income per common share for the year attributable to Methanex Corporation shareholders: | |||||
| Basic net income per common share (note 13) (in usd per share) | |||||
| Diluted net income per common share (note 13) (in usd per share) | |||||
| Weighted average number of common shares outstanding (note 13) (in shares) | |||||
| Diluted weighted average number of common shares outstanding (note 13) (in shares) | |||||
| Attributable to: | |||||
| Methanex Corporation shareholders | |||||
| Non-controlling interests (note 24) | |||||
Loading...
